Literature DB >> 14647210

A high frequency of BRCA2 gene mutations in Polish families with ovarian and stomach cancer.

Anna Jakubowska1, Rodney Scott, Janusz Menkiszak, Jacek Gronwald, Tomasz Byrski, Tomasz Huzarski, Bohdan Górski, Cezary Cybulski, Tadeusz Debniak, Elzbieta Kowalska, Teresa Starzyńska, Małgorzata Ławniczak, Steven Narod, Jan Lubinski.   

Abstract

Germ-line mutations in the BRCA2 gene are associated with a wide range of cancer types, including the breast, ovary, pancreas, prostate and melanoma. In this study, we evaluated the importance of a family history of stomach cancer in predicting the presence of a BRCA2 mutation in Polish patients with ovarian cancer. A BRCA2 mutation was found in eight of 34 women with ovarian cancer and a family history of stomach cancer versus three of 75 women with ovarian cancer and a family history of ovarian cancer, but not of stomach cancer (odds ratio=7.4; 95% CI 1.8-30; P=0.004). The results of this study suggest that, in the Polish population, the constellation of ovarian and stomach cancer predicts the presence of a germ-line BRCA2 mutation and confirms that stomach cancer is part of the spectrum of BRCA2 mutations. It is expected that the penetrance of BRCA2 mutations for stomach cancer will vary from country to country, reflecting local environmental and lifestyle factors.

Entities:  

Mesh:

Year:  2003        PMID: 14647210     DOI: 10.1038/sj.ejhg.5201064

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  14 in total

Review 1.  Hereditary gastric cancer.

Authors:  F Carneiro
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

2.  Prophylactic total gastrectomy in hereditary diffuse gastric cancer: identification of two novel CDH1 gene mutations-a clinical observational study.

Authors:  Linda Bardram; Thomas V O Hansen; Anne-Marie Gerdes; Susanne Timshel; Lennart Friis-Hansen; Birgitte Federspiel
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

3.  HNF4A immunohistochemistry facilitates distinction between primary and metastatic breast and gastric carcinoma.

Authors:  R S van der Post; P Bult; I P Vogelaar; M J L Ligtenberg; N Hoogerbrugge; J H van Krieken
Journal:  Virchows Arch       Date:  2014-04-08       Impact factor: 4.064

4.  Double germline mutations in APC and BRCA2 in an individual with a pancreatic tumor.

Authors:  Caroline Goehringer; Christian Sutter; Matthias Kloor; Johannes Gebert; Emily P Slater; Monika Keller; Irmgard Treiber; Petra Ganschow; Martina Kadmon; Ute Moog
Journal:  Fam Cancer       Date:  2017-04       Impact factor: 2.375

Review 5.  Cancer in Jews: introduction and overview.

Authors:  Henry T Lynch; Wendy S Rubinstein; Gershon Y Locker
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

6.  Hereditary breast and ovarian cancer.

Authors:  Jacek Gronwald; Tomasz Byrski; Tomasz Huzarski; Oleg Oszurek; Anna Janicka; Jolanta Szymanska-Pasternak; Bohdan Górski; Janusz Menkiszak; Izabella Rzepka-Górska; Jan Lubinski
Journal:  Hered Cancer Clin Pract       Date:  2008-06-15       Impact factor: 2.857

7.  Breast Cancers with Ocular Metastases are Early Onset, Non-Familial and Non-BRCA1/BRCA2 Tumours.

Authors:  Katarzyna Królewska; Anna Jakubowska; Stanisław Zajaczek
Journal:  Hered Cancer Clin Pract       Date:  2004-12-15       Impact factor: 2.857

8.  Genetic screening for familial gastric cancer.

Authors:  Carla Oliveira; Gianpaolo Suriano; Paulo Ferreira; Paulo Canedo; Pardeep Kaurah; Rita Mateus; Ana Ferreira; António C Ferreira; Maria José Oliveira; Céu Figueiredo; Fátima Carneiro; Gisela Keller; David Huntsman; José Carlos Machado; Raquel Seruca
Journal:  Hered Cancer Clin Pract       Date:  2004-05-15       Impact factor: 2.857

9.  BRCA1/2 mutation screening in high-risk breast/ovarian cancer families and sporadic cancer patient surveilling for hidden high-risk families.

Authors:  Dace Berzina; Miki Nakazawa-Miklasevica; Jekaterina Zestkova; Karina Aksenoka; Arvids Irmejs; Andris Gardovskis; Dagnija Kalniete; Janis Gardovskis; Edvins Miklasevics
Journal:  BMC Med Genet       Date:  2013-06-14       Impact factor: 2.103

10.  The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers.

Authors:  Helen Cavanagh; Katherine M A Rogers
Journal:  Hered Cancer Clin Pract       Date:  2015-08-01       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.